The market performance of Avidity Biosciences Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $56.00 on 11/13/24, while the lowest value for the same duration was $21.51 on 04/09/25.
52-week price history of RNA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Avidity Biosciences Inc’s current trading price is -41.68% away from its 52-week high, while its distance from the 52-week low is 51.84%. The stock’s price range during this period has spanned from $21.51 to $56.00. In the Healthcare sector, the Avidity Biosciences Inc’s shares surpassed a trading volume of approximately 4.83 million for the day, which was noticeably higher compared to the average daily volume of 9.1.48 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Avidity Biosciences Inc (RNA) has experienced a quarterly rise of 8.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.94B and boasts a workforce of 391 employees.
Making Sense of Trading Volume and Moving Average Data
Examining RNA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RNA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
RNA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 12.31% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -13.89%. Over the past 30 days, the price of RNA has fallen by 13.84%. And in the last five days, it has fallen by -1.54%.
